BV FINANCIAL, INC. ANNOUNCES FINANCIAL RESULTS Exhibit 99.1 Contact: Michael J. Dee Chief Financial Officer (410) 477- 5000 FINANCIAL CONDITION DISCUSSION Total Assets. Total assets were $908.3 million at June 30, 2025, a decrease of $3.5 million, or -0.4%, from $911.8 million at December 31, 2024. The decrease was due primarily to the Company utilizing cash on-hand to repay $15.0 million in borrowings from the FHLB. • Return on average assets and return on average equity for the three months ended June 30, ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from ____ to ____ Commission file number 1-7657 AMERICAN EXPRESS COMPANY (Exact name of registrant as specified in its charter) | New York | | 13-4922250 | | ...

[PART I. Financial Information](index=4&type=section&id=PART%20I.%20Financial%20Information) [Financial Statements](index=4&type=section&id=Item%201.%20Financial%20Statements) For H1 2025, 3M saw flat sales, but net income and operating cash flow declined significantly due to substantial litigation costs and legal settlement payments [Consolidated Statement of Income](index=4&type=section&id=Consolidated%20Statement%20of%20Income) In Q2 2025, net sales increased slightly, but net income fell sharply year-over-year due to higher operating expenses and other non-operating costs Consolidated Statement of Income Highlights (in Millions, except per share amounts) | Metric | Q2 2025 | Q2 2024 | YTD 2025 | YTD 2024 | | :--- | :--- | :--- | :--- | :--- | | **Net Sales** | $6,344 | $6,255 | $12,298 | $12,271 | | **Operating Income** | $1,140 | $1,272 | $2,386 | $2,421 | | **Net Income from Continuing Operations attributable to 3M** | $723 | $1,204 | $1,839 | $1,909 | | **Net Income attributable to 3M** | $723 | $1,145 | $1,839 | $2,073 | | **Diluted EPS from Continuing Operations** | $1.34 | $2.17 | $3.38 | $3.44 | | **Diluted EPS** | $1.34 | $2.07 | $3.38 | $3.73 | [Consolidated Balance Sheet](index=6&type=section&id=Consolidated%20Balance%20Sheet) As of June 30, 2025, total assets decreased due to lower cash balances, while a larger reduction in liabilities led to an increase in total equity Consolidated Balance Sheet Highlights (in Millions) | Account | June 30, 2025 | Dec 31, 2024 | | :--- | :--- | :--- | | **Total Current Assets** | $13,427 | $15,884 | | Cash and cash equivalents | $3,712 | $5,600 | | **Total Assets** | $37,989 | $39,868 | | **Total Current Liabilities** | $7,808 | $11,256 | | Long-term debt | $12,477 | $11,125 | | **Total Liabilities** | $33,638 | $35,974 | | **Total Equity** | $4,351 | $3,894 | [Consolidated Statement of Cash Flows](index=8&type=section&id=Consolidated%20Statement%20of%20Cash%20Flows) For H1 2025, operating activities resulted in a $1.03 billion cash outflow, a stark reversal from the prior year's inflow, driven by legal settlement payments Six Months Ended June 30 Cash Flow Highlights (in Millions) | Cash Flow Category | 2025 | 2024 | | :--- | :--- | :--- | | **Net cash provided by (used in) operating activities** | $(1,033) | $1,788 | | **Net cash provided by (used in) investing activities** | $1,290 | $(856) | | **Net cash provided by (used in) financing activities** | $(2,191) | $3,263 | | **Net increase (decrease) in cash and cash equivalents** | $(1,888) | $4,150 | [Notes to Consolidated Financial Statements](index=10&type=section&id=Notes%20to%20Consolidated%20Financial%20Statements) Notes detail the Solventum spin-off, major restructuring actions, and significant litigation accruals for PFAS and Combat Arms Earplugs [Note 2. Discontinued Operations](index=10&type=section&id=Note%202.%20Discontinued%20Operations) The Health Care business was spun off as Solventum on April 1, 2024, with its historical results now reported as discontinued operations - 3M completed the separation of its Health Care business (Solventum) on April 1, 2024, distributing **80.1% of shares** to 3M stockholders; Solventum's historical results are now reported as discontinued operations[21](index=21&type=chunk) - 3M's continuing involvement with Solventum includes supply and transition agreements, which generated approximately **$40 million in income for Q2 2025** and **$90 million for the first six months of 2025**[22](index=22&type=chunk) [Note 6. Restructuring Actions](index=13&type=section&id=Note%206.%20Restructuring%20Actions) The company is executing major restructuring initiatives, including workforce reductions and exiting PFAS manufacturing, incurring related pre-tax charges - A structural reorganization initiative (2023-2025) is expected to impact **8,000 positions** worldwide to simplify the company; as of Q2 2025, 6,900 positions have been impacted[31](index=31&type=chunk) - The company is exiting all PFAS manufacturing by the end of 2025, a restructuring that has impacted about **1,200 positions** worldwide[33](index=33&type=chunk) Restructuring Charges (in Millions) | Period | 2023-2025 Reorganization | PFAS Exit | | :--- | :--- | :--- | | **Q2 2025 Pre-tax Charge** | $8 | $4 | | **YTD 2025 Pre-tax Charge** | $21 | $9 | | **Q2 2024 Pre-tax Charge** | $35 | Immaterial | | **YTD 2024 Pre-tax Charge** | $138 | Immaterial | [Note 17. Commitments and Contingencies](index=28&type=section&id=Note%2017.%20Commitments%20and%20Contingencies) 3M faces extensive legal proceedings and has recorded significant liabilities for PFAS, Combat Arms Earplugs, and other matters - **Aqueous Film Forming Foam (AFFF) Litigation:** 3M entered into a class-action settlement to resolve drinking water claims by U.S. public water suppliers, agreeing to pay between **$10.5 billion and $12.5 billion** from 2024 through 2036[182](index=182&type=chunk)[184](index=184&type=chunk) - **Combat Arms Earplugs (CAE) Litigation:** In August 2023, 3M reached a settlement to resolve CAE claims, agreeing to contribute up to **$6.0 billion** between 2023 and 2029, with an accrued liability of **$2.4 billion** as of June 30, 2025[262](index=262&type=chunk)[263](index=263&type=chunk)[265](index=265&type=chunk)[266](index=266&type=chunk) - **New Jersey PFAS Settlement:** In May 2025, 3M agreed to a proposed Judicial Consent Order to pay the State of New Jersey up to **$450 million** to resolve statewide PFAS claims, recording a pre-tax charge of **$281 million** in Q2 2025[167](index=167&type=chunk)[168](index=168&type=chunk) Key Litigation Accruals (as of June 30, 2025) | Litigation Matter | Accrued Liability (in Billions) | | :--- | :--- | | **Other Environmental Liabilities (PFAS)** | $7.4 | | **Combat Arms Earplugs (CAE)** | $2.4 | | **Respirator Mask/Asbestos** | $0.474 | [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=55&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management reports modest sales growth and improved adjusted operating margins in Q2 2025, though GAAP results were heavily impacted by litigation costs [Overview](index=55&type=section&id=Overview) Q2 2025 GAAP sales grew 1.4%, but GAAP EPS fell significantly due to litigation costs, while adjusted metrics showed underlying operational improvement - The April 1, 2024 separation of the Health Care business (Solventum) means its historical results are now reported as discontinued operations, and 3M's continuing operations are managed in three new segments[282](index=282&type=chunk)[283](index=283&type=chunk) Q2 2025 Financial Highlights vs. Q2 2024 | Metric | GAAP | Adjusted (Non-GAAP) | | :--- | :--- | :--- | | **Total Sales Change** | 1.4% | 2.3% | | **Organic Sales Change** | 0.6% | 1.5% | | **Operating Income Margin** | 18.0% | 24.5% | | **YoY Margin Change** | (2.3) ppts | +2.9 ppts | | **Earnings Per Diluted Share (EPS)** | $1.34 | $2.16 | | **YoY EPS Change** | (38)% | +12% | [Results of Operations](index=56&type=section&id=Results%20of%20Operations) In Q2 2025, sales growth was led by Asia Pacific, while SG&A expenses and the effective tax rate increased significantly due to litigation and tax law changes - SG&A as a percent of sales increased from 18.1% to **19.9%** in Q2 2025, largely due to increased net costs for the PFAS-related New Jersey Settlement[292](index=292&type=chunk)[293](index=293&type=chunk) - The GAAP effective tax rate for Q2 2025 was **26.6%**, a significant increase from 14.4% in Q2 2024[296](index=296&type=chunk) Q2 2025 vs Q2 2024 Sales Growth by Geography | Region | Total Sales Change | Organic Sales Change | | :--- | :--- | :--- | | **Americas** | 0.0% | 0.6% | | **Asia Pacific** | 3.6% | 2.3% | | **EMEA** | 2.5% | (2.3)% | | **Worldwide** | 1.4% | 0.6% | [Performance by Business Segment](index=59&type=section&id=Performance%20by%20Business%20Segment) In Q2 2025, the Safety and Industrial segment led sales growth, while all three segments expanded operating margins despite varied market conditions - Safety and Industrial growth was driven by electrical markets, industrial adhesives and tapes, and abrasives, benefiting from new product innovation and commercial strategies[307](index=307&type=chunk) - Transportation and Electronics sales were negatively impacted by the planned exit of manufactured PFAS products and weakness in auto builds; excluding special items, **adjusted organic sales grew 1.0%**[311](index=311&type=chunk)[314](index=314&type=chunk) - Consumer segment growth was supported by new product launches and increased investment in advertising in the home improvement division, partially offset by soft consumer discretionary spending[322](index=322&type=chunk) Q2 2025 Performance by Business Segment | Business Segment | Sales (Millions) | Total Sales Change | Operating Income (Millions) | Operating Margin | | :--- | :--- | :--- | :--- | :--- | | **Safety and Industrial** | $2,857 | 3.6% | $721 | 25.3% | | **Transportation and Electronics** | $2,130 | (0.6)% | $462 | 21.7% | | **Consumer** | $1,270 | 0.6% | $268 | 21.1% | [Financial Condition and Liquidity](index=67&type=section&id=Financial%20Condition%20and%20Liquidity) Liquidity remains strong, but H1 2025 operating cash flow was negative and net debt increased due to significant legal settlement payments and share repurchases - Operating cash flow for the first six months of 2025 was a **negative $1.03 billion**, a $2.8 billion decrease from the prior year, primarily due to **$3.1 billion in payments** for the PWS and CAE legal settlements[350](index=350&type=chunk) - In the first six months of 2025, 3M repurchased **$2.2 billion** of its own stock under a new $7.5 billion authorization and paid **$786 million** in dividends to shareholders[355](index=355&type=chunk)[356](index=356&type=chunk) - 3M intends to divest its **19.9% ownership stake in Solventum**, valued at $2.6 billion as of June 30, 2025, within five years of the April 2024 spin-off[335](index=335&type=chunk) Net Debt (Non-GAAP, in Millions) | Component | June 30, 2025 | Dec 31, 2024 | | :--- | :--- | :--- | | Total debt | $13,146 | $13,044 | | Less: Cash, cash equivalents and marketable securities | $4,230 | $7,744 | | **Net debt** | **$8,916** | **$5,300** | [Quantitative and Qualitative Disclosures About Market Risk](index=71&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company reports no material changes in its market risk exposures since the end of the 2024 fiscal year - There have been no material changes in the company's market risk disclosures concerning foreign currency, interest rates, and commodity prices since the 2024 Annual Report[364](index=364&type=chunk) [Controls and Procedures](index=71&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded that disclosure controls and procedures were effective, with no material changes to internal controls during the quarter - Management, including the CEO and CFO, concluded that the company's disclosure controls and procedures are effective as of the end of the quarter[365](index=365&type=chunk) - No changes occurred during the quarter that materially affected, or are reasonably likely to materially affect, the company's internal control over financial reporting[366](index=366&type=chunk) [PART II. Other Information](index=72&type=section&id=PART%20II.%20Other%20Information) [Legal Proceedings](index=72&type=section&id=Item%201.%20Legal%20Proceedings) This section references the detailed discussion of significant legal matters provided in Note 17 of the financial statements - The discussion of legal proceedings is incorporated by reference from Note 17 of the financial statements[369](index=369&type=chunk) [Risk Factors](index=72&type=section&id=Item%201A.%20Risk%20Factors) 3M faces material risks from PFAS and CAE litigation, the planned exit from PFAS manufacturing, the Solventum spin-off, and external economic pressures - **PFAS Risks:** The company faces material risks from PFAS-related liabilities, ongoing litigation (including the PWS Settlement), evolving global regulations, and its plan to exit all PFAS manufacturing by the end of 2025[374](index=374&type=chunk)[377](index=377&type=chunk)[381](index=381&type=chunk) - **CAE Settlement Risks:** The **$6.0 billion Combat Arms Earplugs settlement** is subject to risks, including potential future claims from non-participants and the outcome of any appeals or challenges[402](index=402&type=chunk) - **Solventum Spin-off Risks:** The separation of the health care business presents risks, including failure to realize expected benefits, costs exceeding estimates, potential negative impacts on business relationships, and liabilities under separation agreements[403](index=403&type=chunk)[404](index=404&type=chunk) - **External and Operational Risks:** The company is exposed to risks from worldwide economic and geopolitical conditions, foreign currency fluctuations, supply chain disruptions, and cybersecurity threats[370](index=370&type=chunk)[373](index=373&type=chunk)[393](index=393&type=chunk)[395](index=395&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=80&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) A new $7.5 billion share repurchase program was authorized in February 2025, under which the company repurchased $922 million of stock in Q2 2025 - A new share repurchase program for up to **$7.5 billion** was authorized in February 2025, replacing the prior program[408](index=408&type=chunk) Issuer Purchases of Equity Securities (Q2 2025) | Period | Total Shares Purchased | Average Price Paid per Share | Approx. Value Remaining for Purchase (Millions) | | :--- | :--- | :--- | :--- | | **April 1 - June 30, 2025** | 6,535,611 | $141.06 | $5,655 (as of June 30) |

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended May 31, 2025 Delaware 11-3146460 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 14 Plaza Drive, Latham, New York 12110 (Address of principal executive offices and zip code) OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 19 ...

[Earnings Release Summary](index=1&type=section&id=METROCITY%20BANKSHARES%2C%20INC.%20REPORTS%20EARNINGS%20FOR%20SECOND%20QUARTER%202025) MetroCity Bankshares reported its financial results for Q2 and H1 2025, highlighting net income, EPS, and key performance ratios [Q2 2025 & H1 2025 Performance Highlights](index=1&type=section&id=Second%20Quarter%202025%20Highlights) MetroCity Bankshares reported net income of $16.8 million for Q2 2025, a slight increase from $16.3 million in Q1 2025 but a small decrease from $16.9 million in Q2 2024. For the first six months of 2025, net income grew 4.9% year-over-year to $33.1 million. Key performance indicators for Q2 2025 showed an annualized ROA of 1.87% and an improved net interest margin of 3.77%. The efficiency ratio improved quarter-over-quarter to 37.2% but worsened compared to the prior year Net Income and Diluted EPS | Metric | Q2 2025 | Q1 2025 | Q2 2024 | | :--- | :--- | :--- | :--- | | Net Income | $16.8 million | $16.3 million | $16.9 million | | Diluted EPS | $0.65 | $0.63 | $0.66 | Half-Year Net Income and Diluted EPS | Metric | H1 2025 | H1 2024 | | :--- | :--- | :--- | | Net Income | $33.1 million | $31.6 million | | Diluted EPS | $1.29 | $1.24 | Key Performance Ratios | Performance Ratio | Q2 2025 | Q1 2025 | Q2 2024 | | :--- | :--- | :--- | :--- | | Annualized ROA | 1.87% | 1.85% | 1.89% | | Annualized ROE | 15.74% | 15.67% | 17.10% | | Efficiency Ratio | 37.2% | 38.3% | 35.9% | | Net Interest Margin | 3.77% | 3.67% | 3.66% | [Acquisition of First IC Corporation](index=2&type=section&id=Acquisition%20of%20First%20IC%20Corporation%20and%20First%20IC%20Bank) The company has secured all necessary approvals for its merger with First IC Corporation, with closing anticipated in early Q4 2025 [Merger Details](index=2&type=section&id=Acquisition%20of%20First%20IC%20Corporation%20and%20First%20IC%20Bank) The company has successfully obtained all required regulatory and shareholder approvals for its merger with First IC Corporation, the parent of First IC Bank. The transaction is anticipated to be finalized in the early fourth quarter of 2025, pending the fulfillment of standard closing conditions - On **July 15, 2025**, MetroCity received all required regulatory approvals and non-objections to complete the merger with First IC Corporation[5](index=5&type=chunk) - First IC's shareholders voted to approve the merger on **July 15, 2025**[5](index=5&type=chunk) - The merger is expected to be completed early in the **fourth quarter of 2025**, subject to customary closing conditions[5](index=5&type=chunk) [Results of Operations](index=2&type=section&id=Results%20of%20Operations) This section details the company's financial performance, including net income, net interest income, noninterest income, noninterest expenses, and income tax expense [Net Income](index=2&type=section&id=Net%20Income) Q2 2025 net income increased 3.2% quarter-over-quarter to $16.8 million, primarily driven by higher net interest income. However, it decreased by 0.7% year-over-year due to increased noninterest expenses and a higher provision for credit losses. For the first half of 2025, net income rose 4.9% year-over-year to $33.1 million, largely due to a $4.9 million increase in net interest income - Q2 2025 net income increased by **$529,000 (3.2%)** from Q1 2025, mainly due to a **$1.6 million** increase in net interest income and a **$277,000** increase in noninterest income[6](index=6&type=chunk) - Compared to Q2 2024, net income decreased by **$111,000 (0.7%)** due to higher noninterest expense (**$1.1 million**), income tax expense (**$413,000**), and provision for credit losses (**$257,000**)[6](index=6&type=chunk) - For the six months ended June 30, 2025, net income increased by **$1.6 million (4.9%)** from the same period in 2024, driven by a **$4.9 million** increase in net interest income[7](index=7&type=chunk) [Net Interest Income and Net Interest Margin](index=2&type=section&id=Net%20Interest%20Income%20and%20Net%20Interest%20Margin) Net interest income for Q2 2025 was $32.2 million. The net interest margin expanded by 10 basis points quarter-over-quarter to 3.77%, driven by a 9 basis point decrease in the cost of average interest-bearing liabilities. Year-over-year, the margin increased by 11 basis points, also due to a significant 29 basis point decrease in liability costs. The company's interest rate derivatives contributed a $4.2 million credit to interest expense during the quarter Net Interest Income and Net Interest Margin | Metric | Q2 2025 | Q1 2025 | Q2 2024 | | :--- | :--- | :--- | :--- | | Net Interest Income | $32.2M | $30.6M | $30.7M | | Net Interest Margin | 3.77% | 3.67% | 3.66% | - The QoQ increase in NIM was driven by a **9 basis point** decrease in the cost of average interest-bearing liabilities (to **3.39%**) and a **3 basis point** increase in the yield on average interest-earning assets (to **6.34%**)[11](index=11&type=chunk) - Interest expense decreased by **6.5%** YoY, primarily due to a **38 basis point** decrease in deposit costs[9](index=9&type=chunk) - The company recorded a credit to interest expense of **$4.2 million** from interest rate derivative agreements during Q2 2025[9](index=9&type=chunk)[10](index=10&type=chunk) [Noninterest Income](index=3&type=section&id=Noninterest%20Income) Noninterest income for Q2 2025 increased by 5.1% quarter-over-quarter to $5.7 million, primarily due to higher gains on the sale of residential mortgage loans. This was partially offset by lower gains from SBA loan sales. Year-over-year, noninterest income grew 3.1%, driven by higher gains on SBA loan sales and other income - Q2 2025 noninterest income increased by **$277,000 (5.1%)** from Q1 2025, mainly due to higher gains on sale of residential mortgage loans[13](index=13&type=chunk) Loan Activity (Q2 2025 vs Q1 2025) | Loan Activity (Q2 2025 vs Q1 2025) | Q2 2025 | Q1 2025 | | :--- | :--- | :--- | | SBA Loan Sales | $20.7M | $16.6M | | Mortgage Loan Sales | $54.3M | $40.1M | - For the six months ended June 30, 2025, noninterest income increased by a modest **$62,000 (0.6%)** compared to the same period in 2024[15](index=15&type=chunk) [Noninterest Expense](index=4&type=section&id=Noninterest%20Expense) Noninterest expense in Q2 2025 rose 2.3% quarter-over-quarter to $14.1 million, partly due to $333,000 in expenses related to the First IC merger. Year-over-year, expenses increased by 8.3%, driven by higher salaries, professional fees, and merger costs. Consequently, the efficiency ratio improved to 37.2% from the previous quarter but deteriorated from 35.9% in the prior year's quarter - Q2 2025 noninterest expense increased by **$314,000 (2.3%)** QoQ, including **$333,000** of First IC merger-related expenses[17](index=17&type=chunk) - YoY, noninterest expense increased by **$1.1 million (8.3%)**, primarily due to higher salary and employee benefits, professional fees, and merger-related expenses[18](index=18&type=chunk) Efficiency Ratio | Efficiency Ratio | Q2 2025 | Q1 2025 | Q2 2024 | | :--- | :--- | :--- | :--- | | Ratio | 37.2% | 38.3% | 35.9% | [Income Tax Expense](index=4&type=section&id=Income%20Tax%20Expense) The company's effective tax rate for Q2 2025 was 28.9%, which is higher than the 26.2% in Q1 2025 and 27.5% in Q2 2024. For the first six months of 2025, the effective tax rate was 27.6%, slightly down from 27.9% in the same period of 2024 Effective Tax Rate | Effective Tax Rate | Q2 2025 | Q1 2025 | Q2 2024 | | :--- | :--- | :--- | :--- | | Rate | 28.9% | 26.2% | 27.5% | [Balance Sheet](index=4&type=section&id=Balance%20Sheet) This section provides an overview of the company's financial position, detailing total assets, loan portfolio composition, and deposit trends [Total Assets](index=4&type=section&id=Total%20Assets) As of June 30, 2025, total assets were $3.62 billion, a decrease of 1.2% from the previous quarter, primarily due to a $29.5 million reduction in loans held for sale and an $11.0 million decrease in loans held for investment. Year-over-year, total assets remained relatively unchanged Total Assets | Period End | Total Assets | | :--- | :--- | | June 30, 2025 | $3.62 billion | | March 31, 2025 | $3.66 billion | | June 30, 2024 | $3.62 billion | - The **$44.0 million** quarter-over-quarter decrease in total assets was primarily driven by decreases in loans held for sale (**$29.5 million**) and loans held for investment (**$11.0 million**)[22](index=22&type=chunk) [Loans](index=5&type=section&id=Loans) Loans held for investment totaled $3.12 billion at the end of Q2 2025, down 0.4% from the prior quarter but up 1.0% year-over-year. The quarterly decrease was mainly due to a $26.7 million decline in residential mortgage loans, which was partially offset by growth in commercial real estate and commercial and industrial loans Loans Held for Investment | Period End | Loans Held for Investment | | :--- | :--- | | June 30, 2025 | $3.12 billion | | March 31, 2025 | $3.13 billion | | June 30, 2024 | $3.09 billion | - The quarter-over-quarter decrease in loans was driven by a **$26.7 million** decrease in residential mortgage loans, offset by increases in commercial real estate (**$11.2 million**) and commercial and industrial loans (**$2.3 million**)[25](index=25&type=chunk) [Deposits](index=5&type=section&id=Deposits) Total deposits decreased by 1.7% quarter-over-quarter to $2.69 billion, driven by outflows from interest-bearing demand, money market, and time deposits. In contrast, noninterest-bearing deposits grew by $8.9 million. Uninsured deposits constituted 25.1% of total deposits, up from 24.3% in the prior quarter. The bank maintained significant liquidity with $1.31 billion in available borrowing capacity Total Deposits | Period End | Total Deposits | | :--- | :--- | | June 30, 2025 | $2.69 billion | | March 31, 2025 | $2.74 billion | | June 30, 2024 | $2.75 billion | - Noninterest-bearing deposits increased to **$548.9 million**, representing **20.4%** of total deposits, up from **19.7%** in Q1 2025[27](index=27&type=chunk) - Uninsured deposits were **25.1%** of total deposits at June 30, 2025. The company had **$1.31 billion** of available borrowing capacity[28](index=28&type=chunk) [Asset Quality](index=5&type=section&id=Asset%20Quality) This section assesses the company's credit risk management, including provisions for credit losses and trends in nonperforming assets [Credit Loss Provision and Nonperforming Assets](index=5&type=section&id=Asset%20Quality) The company recorded a provision for credit losses of $129,000 in Q2 2025, a slight decrease from the previous quarter. Asset quality improved, with nonperforming assets (NPAs) falling to $15.2 million, or 0.42% of total assets, from $18.5 million (0.51%) in Q1 2025. The allowance for credit losses (ACL) to total loans remained stable at 0.60%, while the ACL coverage of nonperforming loans increased significantly to 129.76% - A provision for credit losses of **$129,000** was recorded in Q2 2025, compared to **$135,000** in Q1 2025 and a credit provision of **$128,000** in Q2 2024[29](index=29&type=chunk) Nonperforming Assets | Metric | June 30, 2025 | March 31, 2025 | June 30, 2024 | | :--- | :--- | :--- | :--- | | Nonperforming Assets | $15.2 million | $18.5 million | $14.5 million | | NPAs to Total Assets | 0.42% | 0.51% | 0.40% | Allowance for Credit Losses Ratios | Ratio | June 30, 2025 | March 31, 2025 | June 30, 2024 | | :--- | :--- | :--- | :--- | | ACL to Total Loans | 0.60% | 0.59% | 0.58% | | ACL to Nonperforming Loans | 129.76% | 110.52% | 138.11% | [Financial Tables](index=9&type=section&id=Financial%20Tables) This section provides comprehensive financial data, including income statements, balance sheets, performance ratios, and detailed loan and asset quality metrics [Selected Financial Data](index=9&type=section&id=METROCITY%20BANKSHARES%2C%20INC.%20SELECTED%20FINANCIAL%20DATA) This table provides a summary of key financial data, including income statements, per share data, performance ratios, asset quality metrics, and balance sheet ratios for the last five quarters and the six-month periods ended June 30, 2025, and 2024 Selected Financial Data (Dollars in thousands, except per share data) | (Dollars in thousands, except per share data) | Q2 2025 | Q1 2025 | Q2 2024 | H1 2025 | H1 2024 | | :--- | :--- | :--- | :--- | :--- | :--- | | **Net income** | $16,826 | $16,297 | $16,937 | $33,123 | $31,567 | | **Diluted income per share** | $0.65 | $0.63 | $0.66 | $1.29 | $1.24 | | **Return on average assets** | 1.87% | 1.85% | 1.89% | 1.86% | 1.77% | | **Net interest margin** | 3.77% | 3.67% | 3.66% | 3.72% | 3.45% | | **Efficiency ratio** | 37.23% | 38.32% | 35.93% | 37.76% | 36.84% | | **ACL to loans held for investment** | 0.60% | 0.59% | 0.58% | 0.60% | 0.58% | [Consolidated Balance Sheets](index=10&type=section&id=METROCITY%20BANKSHARES%2C%20INC.%20CONSOLIDATED%20BALANCE%20SHEETS%20%28UNAUDITED%29) This table presents the unaudited consolidated balance sheets, detailing assets, liabilities, and shareholders' equity as of the end of the last five quarters Consolidated Balance Sheets (Dollars in thousands) | (Dollars in thousands) | June 30, 2025 | March 31, 2025 | June 30, 2024 | | :--- | :--- | :--- | :--- | | **Total assets** | $3,615,688 | $3,659,725 | $3,615,370 | | **Loans less allowance** | $3,102,786 | $3,113,943 | $3,072,538 | | **Total deposits** | $2,689,493 | $2,737,030 | $2,745,860 | | **Total liabilities** | $3,179,588 | $3,231,756 | $3,208,142 | | **Total shareholders' equity** | $436,100 | $427,969 | $407,228 | [Consolidated Statements of Income](index=11&type=section&id=METROCITY%20BANKSHARES%2C%20INC.%20CONSOLIDATED%20STATEMENTS%20OF%20INCOME%20%28UNAUDITED%29) This table provides the unaudited consolidated statements of income, showing detailed revenue and expense items for the last five quarters and the six-month periods ended June 30, 2025, and 2024 Consolidated Statements of Income (Dollars in thousands) | (Dollars in thousands) | Q2 2025 | Q1 2025 | Q2 2024 | H1 2025 | H1 2024 | | :--- | :--- | :--- | :--- | :--- | :--- | | **Net interest income** | $32,178 | $30,554 | $30,712 | $62,732 | $57,797 | | **Provision for credit losses** | $129 | $135 | $(128) | $264 | $(268) | | **Total noninterest income** | $5,733 | $5,456 | $5,559 | $11,189 | $11,127 | | **Total noninterest expense** | $14,113 | $13,799 | $13,032 | $27,912 | $25,393 | | **Net income** | $16,826 | $16,297 | $16,937 | $33,123 | $31,567 | [QTD Average Balances and Yields/Rates](index=12&type=section&id=METROCITY%20BANKSHARES%2C%20INC.%20QTD%20AVERAGE%20BALANCES%20AND%20YIELDS%2FRATES) This table details the average balances, interest income/expense, and annualized yields/rates for various categories of earning assets and interest-bearing liabilities for the quarters ended June 30, 2025, March 31, 2025, and June 30, 2024 QTD Average Balances and Yields/Rates (For the Three Months Ended) | (For the Three Months Ended) | June 30, 2025 | March 31, 2025 | June 30, 2024 | | :--- | :--- | :--- | :--- | | **Yield on total earning assets** | 6.34% | 6.31% | 6.45% | | **Cost of total interest-bearing liabilities** | 3.39% | 3.48% | 3.68% | | **Net interest spread** | 2.95% | 2.83% | 2.77% | | **Net interest margin** | 3.77% | 3.67% | 3.66% | [YTD Average Balances and Yields/Rates](index=13&type=section&id=METROCITY%20BANKSHARES%2C%20INC.%20YTD%20AVERAGE%20BALANCES%20AND%20YIELDS%2FRATES) This table presents the year-to-date average balances, interest income/expense, and annualized yields/rates for earning assets and interest-bearing liabilities for the six-month periods ended June 30, 2025, and June 30, 2024 YTD Average Balances and Yields/Rates (For the Six Months Ended) | (For the Six Months Ended) | June 30, 2025 | June 30, 2024 | | :--- | :--- | :--- | | **Yield on total earning assets** | 6.33% | 6.36% | | **Cost of total interest-bearing liabilities** | 3.43% | 3.81% | | **Net interest spread** | 2.90% | 2.55% | | **Net interest margin** | 3.72% | 3.45% | [Loan Portfolio Composition](index=14&type=section&id=METROCITY%20BANKSHARES%2C%20INC.%20LOAN%20DATA) This table provides a breakdown of the loan portfolio by category (Construction, Commercial Real Estate, Commercial & Industrial, Residential Real Estate, and Consumer) for the last five quarter-ends, showing both dollar amounts and percentage of total loans Loan Portfolio Composition (Dollars in thousands) | (Dollars in thousands) | June 30, 2025 | % of Total | | :--- | :--- | :--- | | Construction and development | $30,149 | 1.0% | | Commercial real estate | $803,384 | 25.7% | | Commercial and industrial | $73,832 | 2.3% | | Residential real estate | $2,221,316 | 71.0% | | **Gross loans held for investment** | **$3,128,881** | **100.0%** | [Nonperforming Assets](index=14&type=section&id=METROCITY%20BANKSHARES%2C%20INC.%20NONPERFORMING%20ASSETS) This table details the components of nonperforming assets, including nonaccrual loans and other real estate owned (OREO), for the last five quarter-ends. It also includes key asset quality ratios Nonperforming Assets (Dollars in thousands) | (Dollars in thousands) | June 30, 2025 | March 31, 2025 | June 30, 2024 | | :--- | :--- | :--- | :--- | | Nonaccrual loans | $14,448 | $16,823 | $13,004 | | Other real estate owned | $744 | $1,707 | $1,452 | | **Total non-performing assets** | **$15,192** | **$18,530** | **$14,456** | | **Nonperforming assets to total assets** | 0.42% | 0.51% | 0.40% | [Allowance for Loan Losses Reconciliation](index=15&type=section&id=METROCITY%20BANKSHARES%2C%20INC.%20ALLOWANCE%20FOR%20LOAN%20LOSSES) This table provides a reconciliation of the allowance for loan losses, showing the beginning balance, net charge-offs by loan category, provision expense, and the ending balance for the last five quarters and the six-month periods ended June 30, 2025, and 2024 Allowance for Loan Losses Reconciliation (Dollars in thousands, for Q2 2025) | (Dollars in thousands, for Q2 2025) | Amount | | :--- | :--- | | Balance, beginning of period | $18,592 | | Total net charge-offs | $60 | | Provision for loan losses | $216 | | **Balance, end of period** | **$18,748** |

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2025 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No.: 001-12933 AUTOLIV, INC. (Exact name of registrant as specified in its charter) Delaware 51-0378542 (State or other jurisdiction of (I.R.S. Employe ...

FOR IMMEDIATE RELEASE NEWS RELEASE Exhibit 99.1 P.O. Box 10, Manitowoc, WI 54221-0010 For further information, contact: Kevin M LeMahieu, Chief Financial Officer Phone: (920) 652-3200 / klemahieu@bankfirst.com Bank First Announces Net Income for the Second Quarter of 2025 MANITOWOC, Wis, July 18, 2025 -- Bank First Corporation (NASDAQ: BFC) ("Bank First" or the "Bank"), the holding company for Bank First, N.A., reported net income of $16.9 million, or $1.71 per share, for the second quarter of 2025, compare ...

Exhibit 99.2 EARNINGS RELEASE FINANCIAL SUPPLEMENT SECOND QUARTER 2025 TABLE OF CONTENTS | BALANCE SHEET DATA | S-2 | | --- | --- | | AVERAGE BALANCE SHEET DATA | S-3 | | TOTAL COMPANY AVERAGE BALANCE SHEETS AND INTEREST RATES | S-4 | | INCOME STATEMENT DATA | S-5 | | SELECTED DATA AND RATIOS | S-6 | | LOAN COMPOSITION | S-7 | | ALLOWANCE FOR CREDIT LOSSES ON LOANS | S-7 | | CREDIT QUALITY DATA AND RATIOS | S-8 | | SEGMENT DATA | S-9 | | FOOTNOTES | S-12 | S-1 Republic Bancorp, Inc. Second Quarter 2025 Earn ...

News release: IMMEDIATE RELEASE | | | Ally Financial Reports Second Quarter 2025 Financial Results | | | --- | --- | --- | --- | | $1.04 | 10.7% | $436 million | $2.1 billion | | GAAP EPS | RETURN ON COMMON EQUITY | PRE-TAX INCOME | GAAP TOTAL NET REVENUE | | $0.99 | 13.6% | $418 million | $2.1 billion | | ADJUSTED EPS1 | CORE ROTCE1 | CORE PRE-TAX INCOME1 | ADJUSTED TOTAL NET REVENUE1 | FINANCIAL HIGHLIGHTS OPERATIONAL HIGHLIGHTS CEO COMMENTS "I am encouraged and energized by the progress we have made as a ...

F.N.B. Corporation Reports Second Quarter Earnings Record Revenue of $438 Million Grew 6.5% Linked-Quarter With Increased Profitability Driving Record Capital Levels PITTSBURGH, PA – July 17, 2025 – F.N.B. Corporation (NYSE: FNB) reported earnings for the second quarter of 2025 with net income available to common shareholders of $130.7 million, or $0.36 per diluted common share. Comparatively, second quarter of 2024 net income available to common shareholders totaled $123.0 million ($123.7 million on an ope ...